T. Rowe Price Investment Management, Inc. Axsome Therapeutics, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $151 Billion
- Q1 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 266,997 shares of AXSM stock, worth $28 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
266,997Holding current value
$28 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding AXSM
# of Institutions
404Shares Held
36.5MCall Options Held
751KPut Options Held
568K-
Vanguard Group Inc Valley Forge, PA3.88MShares$406 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$346 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.92MShares$306 Million5.58% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$177 Million8.66% of portfolio
-
Geode Capital Management, LLC Boston, MA989KShares$104 Million0.01% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.49B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...